![The primary goal of the Paradigm Registry is to accelerate tumor profiling based on disease biology. [iStock/LilliDay]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/307-218x150.jpeg "AI Algorithm Could Reduce Breast Cancer Mammogram False Positive Rate")
Sponsor: Ambry Genetics
Ambry Genetics is launching a new suite of genetic tests for neurodevelopmental conditions such as Autism, Rett Syndrome, intellectual disorders (ID), and epilepsy. These new panels should aid in making a specific diagnosis and enable physicians to choose the best diagnostic approach for each affected individual. These new genetic screens are composed of either broad panels of genes known to be associated the specific disease or more specific targeted panels, widely recognized by the scientific community to be specifically associated or causes of the various neurodevelopmental disorders.
